 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Genes and HIV
- How Well Will HAART Work? It's All in the Genes, Study Suggests (March 31, 2008)
From aidsmap.com - Researchers Discover Genetic Circuit in HIV That Controls Whether Virus Activates, Remains Dormant (March 19, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Researchers Develop Technique That Prevents HIV From Reproducing, Philadelphia Inquirer Reports (February 11, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Study Finds Genetic Influence on Pace of HIV/AIDS Progression (October 22, 2007)
From U.S. National Institute of Allergy and Infectious Diseases - Biotech Firm Creates Genetically Modified Immune Cells That Resist HIV Infection in Vitro (December 20, 2005)
Sangamo aims to modify patients' immune cells to possess a CCR5 receptor mutation that may make them "uninfectable".
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - The Development Pipeline for Cytokines, Immunomodulators and Gene Therapy (September 29, 2005)
In TAGline, from Treatment Action Group - Human Cells Can "Silence" HIV Genes (May 19, 2005)
A study finds that so-called "RNA silencing," first detected in plants and insects, may contribute to human cells' defense against HIV.
From U.S. National Institute of Allergy and Infectious Diseases - New Strategy for Blocking HIV: Trim5-alpha (November 2004)
A recently discovered protein in animals appears to block HIV infection, though the human form of the protein confers no such benefit.
To read PDF, click here
In Project Inform Perspective, from Project Inform - Gene Therapy for HIV (July 2004)
A brief overview and research update.
To read PDF, click here
In Project Inform Perspective, from Project Inform - Gene Therapy May Block HIV Spread (May 12, 2004)
An experimental treatment has shown some success in re-engineering a person's T cells to more effectively kill HIV.
From BBC News - Gene Therapy: The Ultimate Fusion Blocker? (December 2003)
A recap of recent research on C36, an artificial gene that produces a peptide that acts similarly to T-20.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Interfering With RNA: Kill the Messenger (October 2003)
To read PDF, click here
In Project Inform Perspective, from Project Inform - VPR Gene in HIV "Hijacks" White Blood Cell Replication (August 25, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Mimicked Gene Defect Affords HIV Protection (March 14, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Evaluation of Correlates of Protection in HIV-1 Infected Individuals Spontaneously Controlling Plasma Viral Load in the Absence of Antiretroviral Therapy (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO - New Strategy, "RNA Interference," Proposed for Fighting HIV (October 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Researchers Develop HIV Fighter in RNA (June 4, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Genetic Edge: Fighting Drug Resistance in a Protein's Genes (January 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis - Human Leukocyte Antigens and HIV Disease Progression (July/August 2001)
In TAGline, from Treatment Action Group - Researchers Identify New Genetic Risk Factor for HIV Infection (November 15, 2000)
From U.S. National Institute of Allergy and Infectious Diseases
  |
  |